Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Cash Flow Reinvestment Rate
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Cash Flow Reinvestment Rate of 0.68x as of December 2025, reinvesting $27.77 Million (capex $27.77 Million ) from operating cash flow of $41.05 Million. See how much free cash does Zhengye Biotechnology Holding Limited Or generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zhengye Biotechnology Holding Limited Or.
Annual Cash Flow Reinvestment Rate for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year capital reinvestment analysis for Zhengye Biotechnology Holding Limited Ordinary Shares. See financial agility of Zhengye Biotechnology Holding Limited Or to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +39.5% |
| 2023 | 0.48x | $23.36 Million | $48.18 Million | $11.60 Million | ▼ -84.6% |
| 2022 | 3.15x | $54.66 Million | $17.34 Million | $27.33 Million | ▲ +90.4% |
| 2021 | 1.66x | $52.67 Million | $31.81 Million | $26.40 Million | — |